Does CAPECITABINE Cause Tumour marker increased? 228 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 228 reports of Tumour marker increased have been filed in association with CAPECITABINE (Capecitabine). This represents 0.4% of all adverse event reports for CAPECITABINE.
228
Reports of Tumour marker increased with CAPECITABINE
0.4%
of all CAPECITABINE reports
15
Deaths
39
Hospitalizations
How Dangerous Is Tumour marker increased From CAPECITABINE?
Of the 228 reports, 15 (6.6%) resulted in death, 39 (17.1%) required hospitalization, and 2 (0.9%) were considered life-threatening.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPECITABINE. However, 228 reports have been filed with the FAERS database.
What Other Side Effects Does CAPECITABINE Cause?
Diarrhoea (9,277)
Nausea (6,248)
Palmar-plantar erythrodysaesthesia syndrome (5,294)
Fatigue (5,018)
Death (4,422)
Vomiting (4,111)
Disease progression (3,808)
Off label use (3,193)
Malignant neoplasm progression (2,425)
Asthenia (2,352)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
ANASTROZOLE (142)
Which CAPECITABINE Alternatives Have Lower Tumour marker increased Risk?
CAPECITABINE vs CAPIVASERTIB
CAPECITABINE vs CAPLACIZUMAB
CAPECITABINE vs CAPLACIZUMAB-YHDP
CAPECITABINE vs CAPMATINIB
CAPECITABINE vs CAPREOMYCIN